DB12722InvestigationalProtein Based Therapies
N-sulfoglucosamine sulfohydrolase recombinant is under investigation for the treatment of Mucopolysaccharidosis III and Sanfilippo Syndrome Type A (MPS IIIA).
- Also known as
- sulphamidase
- Code names
- HGT-1410 · SHP-610
Resolves to
Compound
What you can answer from here — as of November 13, 2025
Which companies are running trials of N-sulfoglucosamine sulfohydrolase recombinant, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account